faropenem medoxil 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
analogues of penicillanic acid antibiotics modified in the five-membered ring 5145 141702-36-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • faropenem medoxil
  • faropenem medoxomil
  • faropenem daloxate
  • BAY 56-6854
  • BAY 566854
a faropenem prodrug for treating bacterial infections
  • Molecular weight: 397.40
  • Formula: C17H19NO8S
  • CLOGP: 0.62
  • LIPINSKI: 0
  • HAC: 9
  • HDO: 1
  • TPSA: 111.60
  • ALOGS: -2.53
  • ROTB: 6

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Bacterial infection of skin indication 128936008
Respiratory tract infection indication 275498002




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
C1880735 UMLSCUI
CHEBI:134710 CHEBI
D08919 KEGG_DRUG
6918218 PUBCHEM_CID
DB05659 DRUGBANK_ID
CHEMBL1257070 ChEMBL_ID
C528565 MESH_SUPPLEMENTAL_RECORD_UI
5OK523O4FU UNII

Pharmaceutical products:

None